IRF2BPL gene variants with dystonia: one new Chinese case report

BMC Neurol. 2023 Jan 21;23(1):32. doi: 10.1186/s12883-023-03077-x.

Abstract

Background: The carriers of damaging heterozygous variants in interferon regulatory factor 2 binding protein-like (IRF2BPL), encoding a member of the IRF2BP family of transcriptional regulators, may be affected by a variety of neurological symptoms, such as neurodevelopmental regression, language and motor developmental delay, seizures, progressive ataxia and a lack of coordination, and even dystonia.

Case presentation: We report a Chinese boy who presented with dystonia, dysarthria, and normal development due to nonsense IRF2BPL mutation, with intact imaging and EEG findings but without developmental delays or seizures. Whole-exome sequencing revealed a novel nonsense variant IRF2BPL (NM_024496) Exon C.562C > T (p.Arg188*).

Conclusion: This case report presents a Chinese boy with a novel nonsense variant in IRF2BPL, displaying rapid progressive dystonia and dysarthria, without early developmental delay or epilepsy; expands the IRF2BPL phenotypes in the Chinese population; and raises awareness of patients with IRF2BPL.

Keywords: Dysarthria; Dystonia; IRF2BPL mutation.

Publication types

  • Case Reports

MeSH terms

  • Carrier Proteins / genetics
  • Dysarthria
  • Dystonia* / genetics
  • Dystonic Disorders*
  • East Asian People
  • Humans
  • Language
  • Mutation
  • Nuclear Proteins / genetics
  • Seizures / genetics

Substances

  • Carrier Proteins
  • IRF2BPL protein, human
  • Nuclear Proteins